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Abstract
Oligosaccharides are the third largest component in human milk. This abundance is remarkable because oligosaccharides
are not digestible by the newborn, and yet they have been conserved and amplified during evolution. In addition to
encouraging the growth of a protective microbiota dominated by bifidobacteria, oligosaccharides have anti-infective
activity, preventing pathogens from binding to intestinal cells. Although it would be advantageous adding these valuable
molecules to infant milk formula, the technologies to reproduce the variety and complexity of human milk oligosaccharides
by enzymatic/organic synthesis are not yet mature. Consequently, there is an enormous interest in alternative sources of
these valuable oligosaccharides. Recent research has demonstrated that bovine milk and whey permeate also contain
oligosaccharides. Thus, a thorough characterization of oligosaccharides in bovine dairy streams is an important step towards
fully assessing their specific functionalities. In this study, bovine milk oligosaccharides (BMOs) were concentrated by
membrane filtration from a readily available dairy stream called ‘‘mother liquor’’, and analyzed by high accuracy MALDI FT-
ICR mass spectrometry. The combination of HPLC and accurate mass spectrometry allowed the identification of ideal
processing conditions leading to the production of Kg amount of BMO enriched powders. Among the BMOs identified, 18
have high-molecular weight and corresponded in size to the most abundant oligosaccharides present in human milk.
Notably 6 oligosaccharides contained fucose, a sugar monomer that is highly abundant in human milk, but is rarely
observed in bovine milk. This work shows that dairy streams represent a potential source of complex milk oligosaccharides
for commercial development of unique dairy ingredients in functional foods that reproduce the benefits of human milk.
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Introduction
Human milk oligosaccharides (HMOs) are the third largest
fraction in human milk after lactose and fat, with concentrations of
up to 25 g/L in colostrum, and 10–15 g/L in mature milk, being
about 20-fold greater than in bovine milk [1,2]. The high
concentrations of human milk oligosaccharides combined with
the fact that they are indigestible to humans have raised the
question of the function of these glycans. It is now widely accepted
that HMOs exert several biological activities that are firmly
dependent on their individual chemical structures. The core
structures are mainly based on lactose, which is modified by
enzymatic addition of specific neutral monosaccharides such as N-
acetylglucosamine or N-acetylgalactosamine (HexNAc), galactose
or glucose (Hex) and fucose or deoxyhexose (Fuc) (neutral
oligosaccharides), or acidic components such as N-acetylneurami-
nic acid also known as sialic acid (acidic oligosaccharides) [3].
Various enzymes in the mammary gland combine these monomers
into diverse structures; however, the precise biosynthetic steps
leading to oligosaccharides are still unknown. Systematic charac-
terization of HMOs started in the 1950s, yet analysis remains a
challenging task due to the number of unique structures and their
overall complexity. At present, more than 200 potential structures
have been identified in human milk [4–6]. Neutral oligosaccha-
rides containing N-acetyl-glucosamine (GlcNAc) are the most
relevant factors for the development of the intestinal flora typical
of breast-fed infants [2,7]. High concentrations of oligosaccharides
in milk correlate with a higher diversity of Bifidobacterium species
[8]. Interestingly, activity of many enteric pathogens are blocked
by HMOs, and for several pathogens fucosylated and sialylated
oligosaccharides proved to be the active components [9–13].
HMOs block the ability of a pathogen to bind to, and infect its
host cell, making the host niche of the pathogen effectively
unavailable. HMOs have been consumed by infants for millennia,
and the appearance of pathogenic strains resistant to these
oligosaccharides has never been reported.
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As it becomes more evident that HMOs play a key role in
promoting and maintaining good health in breastfed infants, it
would be advantageous also to provide HMOs not only to
breastfed infants, but also to individuals of all ages through food
supplements. However, it is currently not possible to replicate the
complex oligosaccharides structures by synthetic methods. Several
food companies are actively investigating methods to produce
synthetic oligosaccharides, but only the smallest HMOs have been
reproduced with success and they are not representative of the
complexity and variety of the HMOs. Since HMOs are not
available in large quantities, there is an enormous interest in
identifying alternative sources of these valuable molecules.
Recent research from our group and others has demonstrated
that bovine milk and dairy streams (whey streams) contain several
oligosaccharides, with a number of them structurally similar to
those found in human milk and with some structures common to
both milks [14–18]. As chemical structure of oligosaccharides
influences their biological activities, it is expected that oligosac-
charides from both human and bovine milks would have similar
physiological effects. Consequently, there is interest in adding
these valuable molecules to infant formulas to better match the
nutritional value of these products to breast milk. Indeed,
oligosaccharides are not commercially available from human
milk. Additionally, given the importance of the dairy industry
globally and the well established technologies available within it,
bovine milk and whey streams are being considered as a key
source of oligosaccharides. However, concentration of bovine milk
oligosaccharides (BMOs) is low compared to the one of HMOs. In
this respect, an essential step to increase our capability to
characterize and utilize oligosaccharides from whey streams is to
increase their total abundance. In this study, BMOs were
concentrated by membrane filtration from a readily available
whey stream, and analyzed by high accuracy mass spectrometry.
Whey is the liquid part of milk that separates from the curd
during cheese production. Whey is rich in lactose and protein, but
its high biochemical and chemical oxygen demand make it
expensive to dispose of within environmental regulations. Whey is
a valuable dairy stream for extraction of useful proteins in the form
Figure 1. Fractionation and enrichment of oligosaccharides from mother liquor using membrane filtration technology.
doi:10.1371/journal.pone.0096040.g001
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whey protein concentrates by ultrafiltration (UF) [14,15]. Whey
UF permeate is either disposed of at a cost to the whey processor
or used to produce food grade lactose by crystallization. The liquid
separated from lactose crystals, known as mother liquor, is usually
disposed of to sewage plants or sold as animal feed. Because
mother liquor is already virtually protein-free and most of the
lactose has already been removed, oligosaccharides can be purified
by filtration, which allows retention of oligosaccharides and
removes lactose and salts. Such mother liquor enriched in
oligosaccharides would facilitate commercial use of these bio-
functional ingredients for the food, beverage, and baby food
industries, add value to the waste streams of dairy processing, and
also reduce waste disposal costs for the dairy industry.
The present study employed large-scale centrifugation and
membrane filtration technology to produce powders enriched in
BMOs using mother liquor as a low-cost starting raw material.
Mother liquor was processed employing membranes that frac-
tionated and concentrated BMOs from the other molecules. Mass
spectrometry analysis of oligosaccharides derived from this process
revealed numerous BMOs including eighteen high-molecular
weight species never previously described. Importantly, some of
these novel BMOs contained fucose, a key component of HMOs.
Materials and Methods
Mother liquor used in this study was purchased from Glanbia
plc, Ireland, and transferred refrigerated to Moorepark Technol-
ogy Limited, a pilot plant facility of Teagasc Food Research
Centre, Moorepark Fermoy, Co. Cork, Ireland.
Clarification of Mother Liquor by Centrifugation and
Microfiltration
The initial clarification of mother liquor (2000 kg) to remove
large insoluble material was carried out at 24uC using a pilot plant-
scale Westfalia centrifugal clarifier (Model KNA 3) with a flow
capacity of 1000 L/h (GEA Westfalia Separator GmbH, Ger-
many).
The supernatant fraction obtained from initial clarification was
microfiltered through 0.1 mm molecular weight cut-off (MWCO)
membranes using a pilot scale Tetra Alcross MSF19 microfiltra-
tion plant (Tetra Pak Filtration Systems A/S, Aarhus, Denmark).
The plant has 2 loops, each equipped with tubular ceramic
multichannel membranes (19 filter channels, 102 cm long, and
3 mm channel diameter) enclosed in acid-proof stainless housings.
The total membrane surface area of this plant was 12.5 m2.
Membranes were cleaned according to the manufacturer’s
instructions before and after use. Filtration was performed at
20uC at the following pressures: retentate inlet, 29.3 kPa; retentate
outlet, 11.7 kPa; permeate inlet, 24.1 kPa, and permeate outlet,
15.8 kPa. This step removed the residual insoluble material and
bacteria from the mother liquor, leaving soluble mineral salts,
lactose and oligosaccharides in the microfiltrate.
Fractionation and Enrichment of Milk Oligosaccharides
by Membrane Filtration
The microfiltrate from the microfiltration step was utilized as
the feed to the ultrafiltration plant for fractionation and
enrichment of milk oligosaccharides. The process was carried
out using six, 1-kDa MWCO, spirally wound membranes (Desal
Membrane Products from GE Osmonics, Minnetonka, MN, USA)
Figure 2. MALDI FT-ICR mass spectrum profile of the final sample mother liquor concentrated by membrane filtration. Spectrum was
recorded in positive ionization mode and display all neutral oligosaccharides.
doi:10.1371/journal.pone.0096040.g002
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with a total membrane surface area of 30 m2. Ultrafiltration was
carried out in batch mode at about 10uC, with inlet and outlet
pressures of 551.6 kPa and 413.6 kPa, respectively. The purpose
of this step was to separate and concentrate oligosaccharides from
lactose and mineral salts. The oligosaccharides-rich retentate was
then diafiltered with reverse osmosis water in five consecutive
batch diafiltration steps to further wash out the lactose into the
permeate, thus allowing further enrichment of the retained
oligosaccharides. The final diafiltered retentate was concentrated
by evaporation at 50uC and spray dried with inlet and outlet
temperatures of 120uC and 80uC, respectively. This process
yielded 2.8 kg of bovine milk oligosaccharides-rich powder.
Lactose and sialyllactose, being the smallest oligosaccharides
present in milk and whey streams for which commercial standard
exist, were chosen as markers of oligosaccharide retention and
enrichment during processing.
Quantification of Lactose and Sialyllactose by HPLC
Whey permeate, mother liquor, diafiltered oligosaccharides-
enriched retentate and milk oligosaccharides-rich powder, appro-
priately diluted in water, were analyzed for quantification of
lactose and sialyllactose.
Lactose was quantified by HPLC using an HPX-87C Carbo-
hydrate column (30067.8 mm) (Aminex, Bio-Rad, UK) and a
refractive index detector. The elution was obtained in isocratic
conditions using 9 mM sulphuric acid for 30 min.
Both sialyllactose isomers (39-sialyllactose and 69-sialyllactose)
were quantified by High pH Anion Exchange Chromatography
with Pulsed Amperometric Detection, using a CarboPac PA 100
(25064 mm) connected to a CarboPac PA 100 guard column and
equipped with an electrochemical detector (Dionex Corporation,
Sunnyvale, CA). Elution was carried out with the following
gradient: 100 mM NaOH (Eluent A) and 100 mM NaOH,
500 mM NaAc (Eluent B) (t = 0–3 min 95% Eluent A; t = 3–
13 min 88% Eluent A; t = 13–30 min 50% Eluent A; t = 30–
45 min equilibrated at 95% Eluent A).
Identification of Oligosaccharides by Fourier Transform-
Ion Cyclotron Resonance Mass Spectrometry (FT-ICR MS)
Samples collected during the process were purified by solid-
phase extraction as previously reported to isolate oligosaccharides
prior to mass spectrometry analysis [19]. Analysis of oligosaccha-
rides was performed using a ProMALDI-FT-ICR mass spectrom-
eter (IonSpec, Lake Forest, CA) equipped with a 7.0 Tesla
Figure 3. Collision-induced dissociation (CID) spectrum of peak m/z 1893 [M+Na]. The main fragmentation pattern shows the loss of one
fucose (triangle) followed by the loss of 5 HexNAc (squares) leading to the residue MW 712.16 with composition 3Hex+1HexNAc. The total
composition of ion MW 1893.21 3 Hex +6 HexNAc +1 Fuc (HexNAc: N-Acetylhexsamine-(GlcNAc/GalNAc); Hex: hexose; Fuc: fucose).
doi:10.1371/journal.pone.0096040.g003
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superconducting magnet, hexapole ion accumulation and fitted
with a 355-nm pulsed Nd:YAG laser. Samples were crystallized
using 2,5-dihydroxybenzoic acid as matrix (5 mg/100 mL in a
solution of 50% acetonitrile/50% water (v/v)). The solution of
oligosaccharides (1 mL) was applied to the MALDI probe followed
by addition of 0.01 M NaCl (0.5 mL) and the matrix solution
(1 mL). Sample spots were dried by a technique similar to a fast
evaporation method prior to mass spectrometric analysis. Spectra
were acquired in the positive-ion mode and internally calibrated
using oligosaccharides from other food matrices.
Tandem Mass Spectrometry was performed to obtain compo-
sitional information using sustained off resonance irradiation
(SORI) collision-induced dissociation (CID) to determine the
composition and putative structure of each oligosaccharide. The
precursor ion was isolated and excited to 1000 Hz of their
cyclotron frequency at SORI amplitude of 2.55 V. Nitrogen gas
was used as the collision gas and was pulsed in to maintain a
pressure of 1026 Torr.
Results and Discussion
Enrichment of Milk Oligosaccharides by Membrane
Technology
Initial analysis of various dairy streams led to the identification
and selection of mother liquor as an optimum starting material
because of its higher level of oligosaccharides compared to whey
permeate or skim milk permeate. By comparison to other dairy
streams, mother liquor has a higher sialyllactose to lactose ratio as
measured by HPLC. Typically, whey UF permeates obtained from
industrial dairy production contained between 50 and 65 mg/L of
sialyllactose (39 and 69 sialyllactose) compared with 50 g/L of
lactose, whereas mother liquor samples contained about 170 mg/
L of sialyllactose for a similar level of lactose (49 g/L). Thus,
mother liquor was 2.5- to 3.5-fold more enriched than whey UF
permeates when compared as a ratio of sialyllactose to lactose. The
sialyllactose to lactose ratio (SL/L6100) in the starting mother
liquor was 0.35%. Following membrane filtration and diafiltration,
the diafiltered oligosaccharides-enriched retentate had a sialyllac-
tose to lactose ratio of 14.1%. This represents a 40-fold
enrichment of sialyllactose based on the SL/L ratio. On
evaporating and spray drying the retentate, 2.8 kg of a powder
was obtained with the following composition: 93.7% total solids,
30.3% lactose, 2.8% sialyllactose (39+69), 7.4% true protein, 2.0%
non-protein nitrogen, 24% ash and 27.2% unidentified material
(including oligosaccharides for which commercial standards do not
exist).
Figure 1 shows a schematic flow chart of the membrane
filtration process employed for the enrichment of oligosaccharides,
including the origin of industrial mother liquor from bovine milk.
Earlier work carried out at pilot plant scale in Teagasc Food
Table 1. Composition of neutral oligosaccharides (reduced, sodiated masses) in mother liquor.
Masss [M+Na]+ Hex HexNAc NeuAc NeuGc Fuc R/A %
529.175 3 0 0 0 0 16
570.201 2 1 0 0 0 100
732.253 3 1 0 0 0 52
773.281 2 2 0 0 0 5
894.306 4 1 0 0 0 48
935.334 3 2 0 0 0 26
1097.386 4 2 0 0 0 28
1138.412 3 3 0 0 0 32
1259.444 5 2 0 0 0 4
1300.468 4 3 0 0 0 2
1339.442 8 0 0 0 0 14
1341.497 3 4 0 0 0 1
1421.499 6 2 0 0 0 4
1487.558 3 4 0 0 1 4
1501.493 9 0 0 0 0 21
1503.545 4 4 0 0 0 4
1544.577 3 5 0 0 0 10
1649.610 4 4 0 0 1 5
1665.601 5 4 0 0 0 22
1690.638 3 5 0 0 1 1
1706.630 4 5 0 0 0 12
1747.650 3 6 0 0 0 68
1811.661 5 4 0 0 1 18
1852.694 4 5 0 0 1 10
1893.714 3 6 0 0 1 26
R/A: relative abundance.
Fucosylated species are reported in bold.
doi:10.1371/journal.pone.0096040.t001
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Research Centre Moorepark, Ireland, to evaluate various mem-
brane types, membrane porosity (MWCO), operating conditions
of pressure and feed pH suitable for such a process led to the
selection of spirally-wound membrane with porosity of 1 kDa
MWCO (data not shown). Other reports have also described the
use of 1 kDa MWCO ceramic membrane to separate goat milk
oligosaccharides at laboratory scale [20,21].
Identification of Oligosaccharides by FT-ICR MS
FT-ICR MS analysis out of the oligosaccharides-enriched
powder obtained by the membrane filtration process described
above resulted in the identification of 25 oligosaccharides. The
instrument was ran in positive more and centered to the higher
molecular weight range (up to 4000Da) to enable detecting larger
neutral oligosaccharides. Oligosaccharides carrying negative
charges such as those containing sialic acid produce more intense
signal in negative than positive ion-detection mode of analysis
because they readily deprotonate forming [M-H]-. Conversely,
neutral oligosaccharides are more difficult to detect in negative
mode because their ionization efficiency is lower, in fact neutral
oligosaccharides have a low tendency to form [M-H]-. Therefore,
to improve neutral oligosaccharides detection, we formed a metal-
carbohydrate adduct using Sodium, and then performed the
analyses in positive ion-detection mode, forming the adduct [M+
Na]+. The spectrum of the neutral oligosaccharides found in the
mother liquor powder is shown in Figure 2. Bovine oligosaccha-
rides previously reported in whey [22] and milk/colostrum
[16,17,19] were observed (i.e. those between 500–1000 m/z in
Figure 2). Additionally, more complex oligosaccharides, ranging in
mass from 1257 to 1891 m/z, were observed. The identified
oligosaccharides are listed with their putative composition in
Table 1. The oligosaccharides composition reveals neutral
oligosaccharides containing hexoses (Hex) and N-acetylhexosa-
mines (HexNAc) and six oligosaccharides containing fucose. To
illustrate the mechanism of structural elucidation that led to the
discovery of 6 fucosylated oligosaccharides, one example of
tandem mass spectrometry by Collision-induced dissociation
(CID) is provided in Figure 3. The CID spectrum of peak m/z
1893 [M+Na] shows the loss of one fucose (represented by a
triangle) followed by the loss of 5 HexNAc (represented by squares)
which combined with the residue with composition 3Hex+
1HexNAc (MW 712) leading to a total composition of 3 Hex +6
HexNAc +1 Fucose for ion MW 1893.21.
A main difference between HMOs and BMOs is the fact that
most HMOs are highly fucosylated, while the presence of fucose in
bovine milk has been controversial. Over 20 years ago Saito et al.
[23] reported a single fucosylated oligosaccharide from bovine
colostrum. Since that time numerous studies of BMOs have been
undertaken and have revealed 40 oligosaccharide species and
novel structural detail on BMOs; however no fucosylated species
were described [16,17,24–28]. Indeed, the failure of numerous
studies to identify fucosylated oligosaccharides in bovine milk led
some to question [16] the original observations by Saito et al [23].
However, recently other studies reported the presence of
fucosylated oligosaccharides in goat milk as well as bovine milk
and colostrum [29–33]. For instance, Marin˜o et al. [29],
employing fluorescent labeling of BMOs and their separation by
hydrophilic interaction liquid chromatography (HILIC)-high
performance liquid chromatography (HPLC), detected in bovine
colostrum 2 fucosylated oligosaccharides: Fuc(a1–2)Gal(b1–4)Glc
(29-fucosyllactose) and GalNAc(a1–3)[Fuc(a1–2)]Gal(b1–4)Glc,
the latter was previously reported in bovine [31] and goat
colostrum [33]. However, Marin˜o et al. [29] did not detect 3-
fucosyllactosamine, which was described in bovine colostrum by
Saito et al. [23]. More recently oligosaccharides in bovine
colostrum were also investigated by Aldredge et al [34], who
employing nano-liquid chromatography tandem mass spectrom-
etry, identified 5 fucosylated oligosaccharides that were found to
be in common with human milk. These included 29-fucosyllactose
and 39-fucosyllactose and 3 other oligosaccharides that were found
to be in common with human milk, composed respectively of
2Hex1HexNAc1Fuc; 4Hex1HexNAc1Fuc; and, 3Hex2HexNAc1-
Fuc. In that work, bovine colostrum milk samples were collected
from Jersey and Holstein cows within 12 h of calving. It is well
known that bovine colostrum oligosaccharides composition is
different from that of mature bovine milk [19] and it is reasonable
to expect that it would be even more different in processed cheese
whey obtained from late lactation milk. Furthermore, we
hypothesize that the smaller oligosaccharides (including 29-
fucosyllactose and 39-fucosyllactose) may have passed through
the 1000 Da filtration membrane or even have co-crystallized with
lactose during lactose crystallization in the production of mother
liquor. These possibilities would explain why these oligosaccha-
rides were not detected by mass spectrometric analysis in this
work, whereas larger fucosylated oligosaccharides were identified.
Recently the bovine glycome was established for several dairy
breeds using a combination of several high accuracy mass
spectrometry instruments which revealed the presence of fucosy-
lated oligosaccharides in Jersey breed [32].
The neutral HMOs (containing the monomers N-acetylgluco-
samine and fucose) are considered to be the most relevant factors
for the development of the intestinal microbiota typical for breast-
fed infants, whereas the acidic oligosaccharides (containing the
monomer sialic acid) play an important role in the prevention of
adhesion of pathogenic bacteria to the intestinal epithelial surface
[13]. While specific glycans may act as decoys to inhibit binding of
specific pathogens, the advantage of HMOs is likely due to the
constellation of diverse glycan structures which act in concert to
confer protection to infants from many bacterial, viral, fungal and
other pathogens.
The present work, employing concentration techniques on dairy
streams at pilot scale combined with advanced mass spectrometry,
is the first to discover numerous high-molecular weight fucose-
containing oligosaccharides in a whey stream of bovine milk.
Fucosylated oligosaccharides were confirmed using accurate
tandem mass spectrometry. The structures described herein likely
evaded prior characterization because of their low abundance
relative to the major BMOs. An analogous observation on human
milk was reported by Finke et al. [4]. In that work, they reported
that lactose and predominant oligosaccharides had to be removed
by chromatography to allow the detection of minor high molecular
weight oligosaccharides. In the present work, BMOs were
fractionated and concentrated by membrane filtration and lactose
was completely removed by solid-phase extraction prior to mass
spectrometry.
The discovery of such a large number of fucose-containing
oligosaccharides in bovine milk is promising for translation of these
bioactive molecules into functional foods. HMOs containing
fucose are associated with lower risk of diarrhea and respiratory
diseases in breast-fed infants [35,36]. Thus milk oligosaccharides,
having structures analogous to cell surface receptors, may act as
competitive inhibitors of pathogen binding to their glycoconjugate
receptors. In particular, HMOs containing a 1,2-linked fucose
inhibit the stable toxin-producing Escherichia coli in vitro and its
toxin-induced secretory diarrhea in vitro and in vivo, and Campylo-
bacter jejuni in vitro and in vivo [12,35,37].
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Conclusions
Mother liquor, a low-value by-product of whey and lactose
manufacture, is a rich source of BMOs. Fractionation and
concentration of these oligosaccharides by membrane filtration
led to the production of a powder enriched in oligosaccharides and
low in lactose. Structural analysis of the oligosaccharides present in
this product through high-resolution and sensitive mass spectrom-
etry revealed the presence of previously unreported high-
molecular weight BMOs including some fucosylated structures.
Mother liquor is a better source of milk oligosaccharides than
either mature bovine milk or colostrum. Extraction and enrich-
ment or isolation of oligosaccharides from whey UF permeate or
mother liquor can result in the development of biofunctional
oligosaccharides ingredients for the food, beverage, and infant
formula industries, add value to the waste streams of dairy
production, and also reduce waste disposal costs for the dairy
industry.
The presence of oligosaccharides containing GlcNAc, fucose
and sialic acid make mother liquor potentially an ideal dairy
source for commercial production of oligosaccharides-enriched
ingredients for the food and beverage industries. When the
bioactivities of the new molecules are investigated, not only would
mother liquor reveal a broad spectrum of bioactivities beyond
prebiotic activity, but also would lead to the production of value-
added oligosaccharides ingredients and add value to the waste
streams of whey and lactose manufacture.
Acknowledgments
The authors thank H. Slattery for HPLC analyses and C.J. Dillard and M.
Meyrand for critical reading of this paper.
Author Contributions
Conceived and designed the experiments: RM DB CBJ JBG. Performed
the experiments: RM DB MM. Analyzed the data: DB CC. Contributed
reagents/materials/analysis tools: RM CBJ. Wrote the paper: DB RM
MM JBG.
References
1. Kunz C, Rodriguez-Palmero M, Koletzko B, Jensen R (1999) Nutritional and
biochemical properties of human milk, Part I: General aspects, proteins, and
carbohydrates. Clin Perinatol 26: 307–333.
2. Kunz C, Rudloff S (2008) Potential anti-inflammatory and anti-infectious effects
of human milk oligosaccharides. Adv Exper Med Biol 606: 455–465.
3. Kunz C, Rudloff S (2006) Health promoting aspects of milk oligosaccharides.
Intl Dairy J 16: 1341–1346.
4. Finke B, Stahl B, Pfenninger A, Karas M, Daniel H, et al. (1999) Analysis of
high-molecular-weight oligosaccharides from human milk by liquid chromatog-
raphy and MALDI-MS. Anal Chem 71: 3755–3762.
5. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, et al. (2006) A strategy for
annotating the human milk glycome. J Agric Food Chem 54: 7471–7480.
6. Wu S, Tao N, German JB, Grimm R, Lebrilla CB (2010) Development of an
annotated library of neutral human milk oligosaccharides. J Proteome Res 9:
4138–4151.
7. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB (2006) In vitro
fermentation of breast milk oligosaccharides by Bifidobacterium infantis and
Lactobacillus gasseri. Appl Environ Microbiol 72: 4497–4499.
8. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O (2004) The first prebiotics in
humans: human milk oligosaccharides. J Clin Gastroenterol 38: S80–83.
9. Bode L (2012) Human milk oligosaccharides: every baby needs a sugar mama.
Glycobiology 22: 1147–1162.
10. Kobata A (2010) Structures and application of oligosaccharides in human milk.
Proc Jpn Acad Ser B Phys Biol Sci 86: 731–747.
11. Newburg DS (2009) Neonatal protection by an innate immune system of human
milk consisting of oligosaccharides and glycans. J Anim Sci 87: 26–34.
12. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS
(2003) Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal
beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding
and infection. J Biol Chem 278: 14112–14120.
13. Simon PM, Goode PL, Mobasseri A, Zopf D (1997) Inhibition of Helicobacter
pylori binding to gastrointestinal epithelial cells by sialic acid-containing
oligosaccharides. Infec Immun 65: 750–757.
14. Balagtas JV, Hutchinson FM, Krochta JM, Sumner DA (2003) Anticipating
market effects of new uses for whey and evaluating returns to research and
development. J Dairy Sci 86: 1662–1672.
15. Peters R (2005) Economic aspects of cheese making as influenced by whey
processing options. International Dairy Journal 15: 537–545.
16. Tao N, DePeters EJ, Freeman S, German JB, Grimm R, et al. (2008) Bovine
milk glycome. J Dairy Sci 91: 3768–3778.
17. Tao N, DePeters EJ, German JB, Grimm R, Lebrilla CB (2009) Variations in
bovine milk oligosaccharides during early and middle lactation stages analyzed
by high-performance liquid chromatography-chip/mass spectrometry. J Dairy
Sci 92: 2991–3001.
18. Urashima T, Taufik E, Fukuda K, Asakuma S (2013) Recent advances in studies
on milk oligosaccharides of cows and other domestic farm animals. Biosci
Biotechnol Biochem 77: 455–466.
19. Barile D, Marotta M, Chu C, Mehra R, Grimm R, et al. (2010) Neutral and
acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of
lactation measured by high performance liquid chromatography on a
microfluidic chip and time-of-flight mass spectrometry. J Dairy Sci 93: 3940–
3949.
20. Martinez-Ferez A, Rudloff S, Guadix A, Henkel C, Pohlentz G, et al. (2006)
Goats’ milk as a natural source of lactose-derived oligosaccharides: isolation by
membrane technology. Int Dairy J 16: 173–181.
21. Martinez-Ferez A, Zapata J, Guadix A, Almecija M, Gomez M, et al. (2009)
Obtention of goat milk permeates enriched in lactose-derived oligosaccharides.
Desalination 245: 730–736.
22. Barile D, Tao N, Lebrilla CB, Coisson JD, Arlorio M, et al. (2009) Permeate
from cheese whey ultrafiltration is a source of milk oligosaccharides. Int Dairy J
19: 524–530.
23. Saito T, Itoh T, Adachi S (1987) Chemical structure of three neutral
trisaccharides isolated in free form from bovine colostrum. Carbohydr Res
165: 43–51.
24. Finke B, Mank M, Daniel H, Stahl B (2000) Offline coupling of low-pressure
anion-exchange chromatography with MALDI-MS to determine the elution
order of human milk oligosaccharides. Anal Biochem 284: 256–265.
25. Gopal PK, Gill HS (2000) Oligosaccharides and glycoconjugates in bovine milk
and colostrum. Br J Nutr 84 Suppl 1: S69–74.
26. Martin-Sosa S, Martin MJ, Garcia-Pardo LA, Hueso P (2003) Sialyloligosac-
charides in human and bovine milk and in infant formulas: variations with the
progression of lactation. J Dairy Sci 86: 52–59.
27. McJarrow P, van Amelsfort-Schoonbeek J (2004) Bovine sialyl oligosaccharides:
seasonal variations in their concentrations in milk, and a comparison of the
colostrums of Jersey and Friesian cows. Int Dairy J 14: 571–579.
28. Nakamura T, Kawase H, Kimura K, Watanabe Y, Ohtani M, et al. (2003)
Concentrations of sialyloligosaccharides in bovine colostrum and milk during the
prepartum and early lactation. J Dairy Sci 86: 1315–1320.
29. Marin˜o K, Lane JA, Abrahams JL, Struwe WB, Harvey DJ, et al. (2011) Method
for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydro-
philic interaction chromatography. Glycobiology 21: 1317–1330.
30. Meyrand M, Dallas DC, Caillat H, Bouvier F, Martin P, et al. (2013)
Comparison of milk oligosaccharides between goats with and without the genetic
ability to synthesize alpha s1-casein. Small Ruminant Research 113: 411–420.
31. Nakajima K, Kinoshita M, Matsushita N, Urashima T, Suzuki M, et al. (2006)
Capillary affinity electrophoresis using lectins for the analysis of milk
oligosaccharide structure and its application to bovine colostrum oligosaccha-
rides. Anal Biochem 348: 105–114.
32. Sundekilde UK, Barile D, Meyrand M, Poulsen NA, Larsen LB, et al. (2012)
Natural variability in bovine milk oligosaccharides from Danish Jersey and
Holstein-Friesian breeds. J Agric Food Chem 60: 6188–6196.
33. Urashima T, Bubb WA, Messer M, Tsuji Y, Taneda Y (1994) Studies of the
neutral trisaccharides of goat (Capra hircus) colostrum and of the one- and two-
dimensional 1H and 13C NMR spectra of 69-N-acetylglucosaminyllactose.
Carbohydr Res 262: 173–184.
34. Aldredge DL, Geronimo MR, Hua S, Nwosu CC, Lebrilla CB, et al. (2013)
Annotation and structural elucidation of bovine milk oligosaccharides and
determination of novel fucosylated structures. Glycobiology 23: 664–676.
35. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Meinzen-Derr J, et
al. (2004) Innate protection conferred by fucosylated oligosaccharides of human
milk against diarrhea in breastfed infants. Glycobiology 14: 253–263.
36. Stepans M, Wilhelm S, Hertzog M, Rodehorst T, Blaney S, et al. (2006) Early
consumption of human milk oligosaccharides is inversely related to subsequent
risk of respiratory and enteric disease in infants. Breastfeeding Medicine 1: 207–
215.
37. Crane JK, Azar SS, Stam A, Newburg DS (1994) Oligosaccharides from human
milk block binding and activity of the Escherichia coli heat-stable enterotoxin
(STa) in T84 intestinal cells. J Nutr 124: 2358–2364.
Fucosylated Oligosaccharides in Dairy Streams
PLOS ONE | www.plosone.org 7 May 2014 | Volume 9 | Issue 5 | e96040
